The complexity of Ozempic use for weight loss extends beyond individual health decisions to broader public health implications. This situation calls for continued dialogue between healthcare ...

JD Vance faced backlash for his controversial remarks about Ozempic, a diabetes and weight loss drug. During a podcast ...

Despite her firm denials of ever using Ozempic, the rumors persist ... with many attributing her new look to the controversial drug. The public's fascination with her transformation highlights ...

A former head of the US Food and Drug Administration cut his body fat in half using GLP-1 drugs. In his book, he compares the harm of the food and tobacco industries.

Billionaire entrepreneur and top adviser to President-elect Donald Trump, Elon Musk, touted that he has reaped the benefits of a controversial ... improve public health" than making Ozempic ...

after its meteoric yet controversial rise in 2023 and 2024, is the Ozempic phenomenon. A prescription drug, Ozempic has been making its presence felt among Holly and Bolly stars, in fashion and ...

Golden Globes host Nikki Glaser caused some controversy with her March 24 appearance on The Tonight Show after she proudly advocated for Ozempic and plastic surgery. And she further stoked the ...

Kennedy Jr.'s "MAHA" credentials, but who has caused controversy across political lines. From autism linked to vaccines, obesity in America and the use of Ozempic to interviews on Joe Rogan and ...

The Food and Drug Administration is warning people to be on the lookout for counterfeit Ozempic, the diabetes drug that many people use off-label for weight loss. The federal agency and Novo ...

A National Geographic investigation explores the controversial lab-for-hire industry ... than half of the animals sourced from Cambodia. Ozempic and Wegovy, medications that have become ...

In the summer of 2022, I decided to try taking Ozempic to lose weight. At the time, I was an early adopter. The media frenzy about GLP-1 agonists hadn't yet started. Even my own doctor was ...